ViBA

Structure-based virtual screening identifies ethyl rosmarinate as a SLC1A6-targeted therapeutic candidate for bladder cancer.

Wang H, Liu H, Ma X · Frontiers in pharmacology · 2026 · Article

10.3389/fphar.2026.1895264

Verified evidence

Network node removal

10129d5f-fd10-58a6-959e-0744045dce6a
Network response and activityPathway activity and enrichment

Prediction source Version of record · PDF page(s) 17, 19

Study f93ed617-3d3f-5b3f-9900-fd41a6aebb53 · Prediction record (JSON)

Prediction fields

Comparator
baseline_or_control · PDF page(s) 19
Reference type
simulated_against_baseline · PDF page(s) 17, 19
Scenario
within_model_scenario_comparison · PDF page(s) 17, 19

Model evaluation

16a9507c-e6c9-5fca-9e84-1c6ee1fae57b
Risk and probability estimatesStatistical test outcomesSurvival and mortality

Prediction source Version of record · PDF page(s) 11

Study f93ed617-3d3f-5b3f-9900-fd41a6aebb53 · Prediction record (JSON)

Prediction fields

Endpoint
hazard_ratio · PDF page(s) 11
Family
clinical_outcomes · PDF page(s) 11
Measured variable
survival_overall · PDF page(s) 11, 12
Metric
hazard_ratio · PDF page(s) 11
Outcome target
overall_survival · PDF page(s) 11
Prediction target type
future_clinical_outcome · PDF page(s) 11
Result operation
survival_association · PDF page(s) 11

Validation Direct comparison · Same source · Sample overlap · Indeterminate · Matched conditions · Not statistically significant